focus -WSS

focus

author：leisure time 2025-09-30 00:48:19 - browse：5911

UnitedHealth's CEO Andrew Witty stares into the camera at a hearing with his fingers locked — politics coverage from STAT — Kent Nishimura/Getty Images

On Wednesday, UnitedHealth CEO Andrew Witty appeared before Congress to answer for what lawmakers called a “single attack [that] kicked off a cascading series of crises that are unmasking some deep vulnerabilities in the core of our health care system”: the February Change Healthcare cyberattack that is still disrupting payment processing across the country.

Senators repeatedly interrupted Witty, trying to keep him to concrete answers and promises. Lawmakers on both sides of the aisle were exasperated with UnitedHealth. At one point, Sen. Thom Tillis (R-N.C.) held up a fifth-edition copy of “Hacking for Dummies” during the hearing.

“This is some basic stuff that was missed,” he said, referring to the fact that the hackers gained access to a Change server that didn’t have multi-factor authentication, a big problem for a company whose business is digital data. “So shame on internal audit, external audit and your system folks, those tasked with redundancy, they’re not doing their job. And as a result, we have a data breach.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： GSK Flovent asthma inhalers replaced by authorized generics

focus

knowledge

WSS

The FDA must approve intranasal treatments for anaphylaxis

Plastic surgeons increase patient psychiatric screenings

U.K. sequencing study surfaces new findings about tumor DNA

3 medical device trends to watch in 2024

Why psychiatrists like me stop taking insurance

Antibiotic resistance and the global rise in human conflict

Wikipedia

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

Medicare proposal to cover medical devices draws a mixed reaction

How a scoliosis diagnosis changed the life of one young dancer

Trump demands the U.S. pay no more for drugs than other countries … again

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Drug repurposing or repositioning? The language matters

Nurses recount patients attacks

The high cost of giving birth even with insurance

J&J to buy cancer drug developer Ambrx Biopharma

How one medical school became remarkably diverse

Stop the failed accountable care organization experiment

leisure time

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Goldman Sachs launches $650M fund for life science investments

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

SCOTUS questions limit to govt efforts to fight misinformation

New weight loss drugs work. But how can they best be used?

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

focus

knowledge

knowledge

leisure time